Shen Shu-Xia, Liu Yun
Department of Neurology, Yulin No.2 Hospital, Yulin, Shaanxi, China.
Medicine (Baltimore). 2018 Jun;97(26):e11264. doi: 10.1097/MD.0000000000011264.
This retrospective study evaluated the effect of using neuromuscular electrical stimulation (NMES) for the treatment of post-stroke urinary incontinence (PSUI) among female population in China.A total of 163 eligible patients with PSUI were included in this study. Of these, 103 patients were assigned to a treatment group, and 60 subjects were assigned to a control group. All patients in both groups received bladder training. In addition, patients in the treatment group also received NMES. All patients were treated for a total of 8 weeks. The outcome measurements included the amount of urine leakage, urinary symptoms and quality of life. The urinary symptoms were measured by the Bristol Female Urinary Symptoms Questionnaire (BFUSQ) score, and the quality of life was assessed by the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score. In addition, adverse events were also documented in this study.After 4-week treatment, patients who received NMES did not exert better outcomes in the amount of urine leakage, urinary symptoms, measured by BFUSQ scale, and the quality of life, assessed by ICIQ-SF scale. However, after 8-week treatment, patients in the treatment group showed greater effect in reducing the amount of urine leakage (P < .01), enhancing urinary symptoms, as measured by BFUSQ scale (P < .01), and improving the quality of life, as assessed by ICIQ-SF scale (P < .01), compared with patients in the control group. In addition, no adverse event was recorded during the period of 8-week treatment in this study.The results of this study indicated that NMES may benefit for patients with PSUI after 8-week treatment. Future studies should focus on warranting the results of this study.
这项回顾性研究评估了在中国女性人群中使用神经肌肉电刺激(NMES)治疗中风后尿失禁(PSUI)的效果。本研究共纳入163例符合条件的PSUI患者。其中,103例患者被分配到治疗组,60例受试者被分配到对照组。两组所有患者均接受膀胱训练。此外,治疗组患者还接受NMES治疗。所有患者共治疗8周。结局指标包括漏尿量、泌尿系统症状和生活质量。泌尿系统症状通过布里斯托尔女性泌尿系统症状问卷(BFUSQ)评分进行测量,生活质量通过国际尿失禁咨询委员会简表(ICIQ-SF)评分进行评估。此外,本研究还记录了不良事件。治疗4周后,接受NMES治疗的患者在漏尿量、通过BFUSQ量表测量的泌尿系统症状以及通过ICIQ-SF量表评估的生活质量方面并未取得更好的结果。然而,治疗8周后,与对照组患者相比,治疗组患者在减少漏尿量(P<0.01)、通过BFUSQ量表测量改善泌尿系统症状(P<0.01)以及通过ICIQ-SF量表评估提高生活质量(P<0.01)方面显示出更大的效果。此外,本研究在8周治疗期间未记录到不良事件。本研究结果表明,NMES在治疗8周后可能对PSUI患者有益。未来的研究应着重验证本研究的结果。